Metformin er
Pro Research Analysisby 
Searched over 200M research papers for "metformin er"
Consensus Meter
Metformin Extended Release (ER): Efficacy and Mechanisms
Introduction to Metformin ER
Metformin extended release (ER) is a formulation designed to provide effective glycemic control with once-daily dosing for patients with Type 2 diabetes mellitus. This formulation has similar bioavailability to conventional immediate-release (IR) metformin and has been shown to maintain good glycemic control over extended periods.
Metformin ER in Glycemic Control
Clinical trials have demonstrated that metformin ER is effective in managing blood glucose levels both as a monotherapy and in combination with other antidiabetic agents like sulfonylurea. Over a 24-week period, patients on metformin ER experienced significant improvements in glycemic control, which were sustained during an additional 24-week open-label extension study. The once-daily dosing regimen of metformin ER at 1500 mg/day was found to be as effective as the twice-daily dosing of metformin IR at the same total daily dose, with a favorable tolerance profile.
Metformin and Endometrial Receptivity in PCOS
Metformin has been studied for its role in improving endometrial receptivity (ER) in women with polycystic ovary syndrome (PCOS). A meta-analysis of 62 studies involving 6571 patients revealed that metformin significantly increased endometrial thickness and reduced the endometrial artery resistance index. These changes were associated with improved clinical pregnancy rates and reduced miscarriage rates in PCOS patients, suggesting that metformin enhances endometrial receptivity.
Metformin's Role in ER Stress and Inflammation
Metformin has been shown to alleviate endoplasmic reticulum (ER) stress and inflammation, which are critical factors in various diseases, including diabetes and neurodegenerative conditions. In rat astrocytes, metformin inhibited ER stress and inflammation induced by high glucose levels by disrupting the interaction between caveolin1 and AMPKα, highlighting a potential therapeutic mechanism for metformin in managing hyperglycemia-induced neuropathological conditions.
Metformin in Diabetic Periodontal Tissue Remodeling
Research has indicated that metformin can restore ER homeostasis in diabetic periodontal tissue, which is crucial for tissue repair. Metformin achieves this by modulating intracellular miR-129-3p levels and enhancing exosome release, thereby rescuing the impaired osteogenesis of periodontal ligament stem cells. This mechanism was further supported by the development of a nanocarrier for sustained local delivery of metformin, which significantly improved periodontal tissue remodeling in diabetic rats.
Metformin and Pancreatic Beta Cell Protection
Metformin has protective effects against ER stress-induced apoptosis in pancreatic beta cells, which is vital for maintaining insulin synthesis and secretion in Type 2 diabetes. The drug activates the AMPK-PI3K-c-Jun NH2 pathway, reducing ER stress and preventing cell death. This mechanism underscores the importance of metformin in preserving pancreatic beta cell function and combating diabetes-related beta cell destruction.
Metformin in Cancer Research
Despite its potential benefits in diabetes management, metformin's efficacy in cancer prevention, particularly in mammary cancer models, has shown mixed results. Studies on rodent models of ER+ and ER- mammary cancers revealed that metformin did not decrease tumor incidence and, in some cases, increased tumor multiplicity. These findings suggest that while metformin has promising antidiabetic and anti-inflammatory properties, its role in cancer prevention requires further investigation .
Conclusion
Metformin ER is a valuable tool in the management of Type 2 diabetes, offering effective glycemic control with a convenient once-daily dosing regimen. Beyond its antidiabetic effects, metformin shows promise in improving endometrial receptivity in PCOS, alleviating ER stress and inflammation, and protecting pancreatic beta cells. However, its efficacy in cancer prevention remains inconclusive, highlighting the need for further research to fully understand its potential in oncology.
Sources and full results
Most relevant research papers on this topic